Docetaxel 20mg Injection
Injection is an anti-cancer medication used for the treatment of breast cancer, non-small cell lung cancer, prostate cancer and cancers of head and neck.
Docetaxel 20mg Injection contains docetaxel, an anticancer medicine belonging to the taxane class of chemotherapy drugs. It is used to treat certain types of cancer, including breast, lung, prostate, stomach, and head and neck cancers, either alone or in combination with other medicines.
Docetaxel 20mg Injection contains docetaxel as its active ingredient. It is a taxane-based chemotherapy medicine used in the treatment of certain cancers.
It works by interfering with the structures that cancer cells need to divide and multiply. Docetaxel may be prescribed alone or alongside other chemotherapy medicines, depending on the cancer type and treatment plan.
Docetaxel 20mg Injection may be prescribed to:
Treat certain types of breast cancer.
Treat non-small cell lung cancer.
Treat metastatic castration-resistant prostate cancer.
Treat certain cases of advanced stomach cancer.
Treat locally advanced squamous cell carcinoma of the head and neck.
The appropriate treatment combination, dose, and duration should be determined by an oncologist based on the cancer type, stage, previous treatment, and the patient's overall health.
Docetaxel works by targeting microtubules, which are structures that help cells maintain their shape and divide. It stabilises these structures and prevents them from functioning normally during cell division.
This interferes with the multiplication of cancer cells and can lead to their death. The treatment response develops over time and is assessed by the oncology team through clinical evaluations and appropriate tests.
Take Docetaxel exactly as prescribed by your healthcare professional.
Administration: Docetaxel is administered as an intravenous (IV) infusion by a qualified healthcare professional in a medical facility.
Frequency: The treatment schedule depends on the type of cancer, chemotherapy combination, and individual treatment plan.
Infusion: The medicine is generally administered over approximately one hour, according to the prescribed protocol.
Premedication: Corticosteroids may be prescribed before treatment to help reduce certain risks, including fluid retention and hypersensitivity reactions.
Monitoring: Blood counts and liver function may be checked before treatment cycles to assess whether treatment can continue.
Dose adjustments: The oncologist may adjust or delay treatment depending on side effects, blood test results, and treatment response.
Do not attempt to administer this injection yourself or change the treatment schedule without consulting your oncology team.
Tell your doctor or pharmacist about your medical history and all medicines, supplements, and herbal products you use before starting docetaxel treatment.
Particular caution is required if you:
Have liver problems: Reduced liver function may increase the risk of serious side effects.
Have low blood cell counts: Docetaxel can reduce white blood cells, red blood cells, and platelets, increasing the risk of infections, anaemia, and bleeding.
Have a history of allergies: Inform your doctor about previous allergic reactions to docetaxel or medicines containing polysorbate 80.
Have fluid retention: Docetaxel can cause swelling due to fluid accumulation in the body.
Have existing nerve problems: Treatment may cause or worsen numbness, tingling, or other nerve-related symptoms.
Have a history of severe gastrointestinal problems: Certain intestinal complications may occur during treatment.
Possible medicine interactions include:
CYP3A4 inhibitors: Certain antifungal medicines, antibiotics, and other drugs may increase docetaxel exposure.
CYP3A4 inducers: Some medicines may reduce docetaxel exposure and affect treatment response.
Other chemotherapy medicines: Combining docetaxel with other anticancer medicines may increase certain side effects and require close monitoring.
Check all possible interactions with your oncologist or pharmacist before starting treatment.
Docetaxel may cause harm to an unborn baby and is generally not recommended during pregnancy unless a specialist determines that treatment is necessary. Pregnancy status should be assessed before treatment where applicable, and effective contraception is recommended during treatment and for the period specified in the product information after the last dose.
Breastfeeding is generally not recommended during docetaxel treatment because the medicine may pose risks to a nursing infant. Discuss pregnancy planning and breastfeeding with your oncologist before starting treatment.
Like all medicines, Docetaxel can cause side effects, although not everyone experiences them.
Common or recognised side effects may include:
Nausea and vomiting
Diarrhoea or constipation
Hair loss
Fatigue and weakness
Loss of appetite
Mouth sores or inflammation
Muscle and joint pain
Changes in fingernails or toenails
Numbness or tingling in the hands and feet
Swelling due to fluid retention
Increased risk of infections due to reduced white blood cell counts
Seek immediate medical attention if you experience difficulty breathing, severe allergic reactions, fever or chills, unusual bleeding, severe abdominal pain, or serious skin reactions such as blistering or peeling.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Store Docetaxel according to the instructions shown on the original product packaging.
Keep the injection in its original packaging until required.
Protect it from unsuitable storage conditions and direct light where specified by the manufacturer.
Follow the manufacturer's instructions regarding refrigeration, temperature, and handling.
Keep out of reach of children.
Do not use the injection after its expiry date.
Preparation, dilution, and handling should be performed by qualified healthcare professionals according to the product instructions.
Storage requirements may vary depending on the manufacturer and formulation.
Docetaxel 20mg Injection is a chemotherapy medicine used to treat certain cancers, including breast, non-small cell lung, prostate, stomach, and head and neck cancers. It may be administered alone or with other anticancer medicines.
Docetaxel interferes with microtubules, which are essential structures involved in cell division. This prevents cancer cells from dividing normally and can lead to their death.
Docetaxel is administered through an intravenous infusion by a qualified healthcare professional. It must be given in a medical facility equipped to manage possible infusion-related complications.
The treatment schedule depends on the type of cancer, the combination of medicines being used, and the patient's response and tolerance. Your oncologist will determine the appropriate treatment intervals.
Yes, hair loss is a recognised side effect of docetaxel treatment. Hair loss may vary between individuals and may improve after treatment ends.
Blood tests help monitor white blood cells, red blood cells, platelets, and liver function. These checks help the oncology team assess treatment tolerance and identify complications that may require treatment adjustments.
Docetaxel can cause harm to an unborn baby and is generally avoided during pregnancy. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and treatment options with their oncologist.